COMMUNIQUÉS West-GlobeNewswire

Establishment Labs to Present at Jefferies 2019 Healthcare Conference
20/05/2019
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
20/05/2019
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and [...]
Principia Presents Phase 1 Data of PRN1371 in Patients with Metastatic Bladder Cancer
20/05/2019
-- FGFR inhibitor PRN1371 well tolerated in 36 patients in dose-escalation phase; dose expansion in metastatic urothelial carcinoma patients ongoing -- SOUTH SAN FRANCISCO, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- [...]
TYME Announces Notification of Issuance of U.S. Patent Covering SM-88 Single Agent Treatment for Cancers
20/05/2019
Complements strong patent portfolio covering SM-88 in use with other conditioning agents NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing [...]
resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International Conference for RTB101 as a Potential Immunotherapy to Reduce the Incidence of Respiratory Tract Infections in Patients 65 Years of Age and Older with Asthma
20/05/2019
RTB101 10 mg once daily was observed to reduce the rate of laboratory-confirmed Respiratory Tract Infections (RTIs) by 78.7% (p=0.001) and the rate of all RTIs (with or without laboratory confirmation) by 66.4% (p=0.003 [...]
Results of Dyspnea Study Using Dynamic Digital Radiography to be Presented at ATS 2019
20/05/2019
WAYNE, N.J. and DALLAS, May 20, 2019 (GLOBE NEWSWIRE) -- Clinicians from Mount Sinai St. Luke’s in New York will present the results of a clinical study examining the use of Konica Minolta's new Dynamic Digital [...]
Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors
20/05/2019
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Biogen Recommends Stockholders Reject the Below-market Mini-tender Offer by TRC Capital Corporation
20/05/2019
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Corporation (TRC Capital) to purchase up to [...]
Misonix to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29
20/05/2019
FARMINGDALE, N.Y., May 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Ascendis Pharma A/S Announces Preliminary Data from Single Arm Phase 3 fliGHt Trial Demonstrated TransCon™ hGH was Safe and Well-Tolerated in Pediatric Subjects Previously Treated with Daily Growth Hormone
20/05/2019
- Provides real-world experience for switching pediatric growth hormone deficiency subjects one to 17 years old from daily growth hormone to once-weekly TransCon hGH - - Data included safety and efficacy for TransCon [...]
CURE Pharmaceutical Expands Leadership Team with Key New Hires
20/05/2019
OXNARD, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of four key hires to their growing leadership team. [...]
CureVac Enters into an Exclusive Sponsored Research Agreement for Discovery Research in mRNA-based Eye Therapy Candidates with the Schepens Eye Research Institute, Harvard Medical School and the Massachusetts Eye and Ear Infirmary
20/05/2019
TÜBINGEN, Germany and BOSTON, May 20, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it has entered into a sponsored research [...]
Dova Pharmaceuticals to Present at the UBS Global Healthcare Conference
20/05/2019
DURHAM, N.C., May 20, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Jason Hoitt, Chief Commercial Officer, will present a company overview at the UBS Global Healthcare [...]
Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility
20/05/2019
Processing license permits Pure Sunfarms to extract and process cannabis to advance its product development strategy VANCOUVER, British Columbia, May 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“ [...]
ReWalk Robotics Appoints Chunlin (Allen) Han to its Board of Directors
20/05/2019
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) announced today that the Company has appointed Mr. Chunlin (Allen) Han to the [...]
Constellation Pharmaceuticals Presents Poster on Studies of CPI-0209 in Bladder Cancer at AACR Meeting
20/05/2019
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST) today announced that Dr. Patricia Keller, Senior Scientist at Constellation Pharmaceuticals, presented a poster [...]
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress
20/05/2019
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Axovant to Present at 2019 RBC Capital Markets Global Healthcare Conference
20/05/2019
BASEL, Switzerland, May 20, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu, M.D., chief executive [...]
Vistin Pharma ASA: Proposal from the Election Committee
20/05/2019
Oslo, Norway, 20 May 2019 Vistin Pharma ASA (OSE: VISTIN), reference is made to the announcement on 30 April 2019 regarding the annual general meeting to be held on 22 May. Please find attached the proposal from the [...]

Pages